首页> 外国专利> VACCIN UNIVERSEL BASÉ SUR DES NÉO-ANTIGÈNES TUMORAUX PARTAGÉS POUR LA PRÉVENTION ET LE TRAITEMENT DE CANCERS À INSTABILITÉS MICRO-SATELLITAIRES (MSI)

VACCIN UNIVERSEL BASÉ SUR DES NÉO-ANTIGÈNES TUMORAUX PARTAGÉS POUR LA PRÉVENTION ET LE TRAITEMENT DE CANCERS À INSTABILITÉS MICRO-SATELLITAIRES (MSI)

摘要

This invention relates to a method of selecting a collection of frame- shift peptides (CFSPs) to produce a universal cancer vaccine peptide collection (CVP) for prophylaxis and treatment of patients with hereditary and sporadic micro- satellite instability (MSI) tumors. This invention relates as well to a method of producing a CVP by selecting a subset of frame-shift peptides (FSPs) from the CFSP and optionally modifying the FSP's amino acid (aa) sequence to generate modified FSPs (mFSPs). The invention further relates to nucleic acid collections encoding a CVP of FSPs and/or mFSPs in one or more vaccine vectors that can be used also simultaneously. These CVPs, nucleic acids and vectors are used for the prophylaxis or treatment of MSI cancers.

著录项

  • 公开/公告号EP3652606A1

    专利类型

  • 公开/公告日2020.05.20

    原文格式PDF

  • 申请/专利权人

    申请/专利号EP18742985.7

  • 发明设计人

    申请日2018.07.12

  • 分类号

  • 国家 EP

  • 入库时间 2022-08-21 10:52:45

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号